Northwest & Ethical Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.32M | Sell |
221,058
-149,514
| -40% | -$3.91M | 0.12% | 131 |
|
|
2026
Q1 | $10.4M | Sell |
370,572
-45,490
| -11% | -$1.21M | 0.24% | 107 |
|
|
2025
Q4 | $10.4M | Sell |
416,062
-148,595
| -26% | -$3.75M | 0.23% | 112 |
|
|
2025
Q3 | $14.4M | Sell |
564,657
-47,286
| -8% | -$1.17M | 0.34% | 91 |
|
|
2025
Q2 | $14.8M | Buy |
611,943
+402,490
| +192% | +$9.39M | 0.37% | 89 |
|
|
2025
Q1 | $5.31M | Sell |
209,453
-55,619
| -21% | -$1.46M | 0.14% | 170 |
|
|
2024
Q4 | $7.03M | Buy |
265,072
+1,541
| +0.6% | +$41.8K | 0.19% | 155 |
|
|
2024
Q3 | $7.63M | Buy |
263,531
+7,799
| +3% | +$228K | 0.2% | 147 |
|
|
2024
Q2 | $7.16M | Buy |
255,732
+19,882
| +8% | +$547K | 0.21% | 141 |
|
|
2024
Q1 | $6.54M | Sell |
235,850
-154,329
| -40% | -$4.28M | 0.19% | 150 |
|
|
2023
Q4 | $11.2M | Buy |
390,179
+25,533
| +7% | +$772K | 0.35% | 100 |
|
|
2023
Q3 | $12.1M | Buy |
364,646
+141,058
| +63% | +$4.99M | 0.41% | 82 |
|
|
2023
Q2 | $8.2M | Buy |
223,588
+65,941
| +42% | +$2.57M | 0.26% | 122 |
|
|
2023
Q1 | $6.43M | Buy |
157,647
+13,767
| +10% | +$595K | 0.21% | 141 |
|
|
2022
Q4 | $7.37M | Sell |
143,880
-71,620
| -33% | -$3.43M | 0.25% | 127 |
|
|
2022
Q3 | $9.43M | Buy |
215,500
+10,071
| +5% | +$489K | 0.38% | 85 |
|
|
2022
Q2 | $10.8M | Buy |
205,429
+79,027
| +63% | +$4.03M | 0.4% | 81 |
|
|
2022
Q1 | $6.54M | Sell |
126,402
-55,181
| -30% | -$2.86M | 0.21% | 130 |
|
|
2021
Q4 | $10.7M | Buy |
181,583
+111,178
| +158% | +$5.51M | 0.32% | 95 |
|
|
2021
Q3 | $3.03M | Buy |
70,405
+16,111
| +30% | +$714K | 0.1% | 205 |
|
|
2021
Q2 | $2.13M | Sell |
54,294
-74,370
| -58% | -$2.89M | 0.07% | 235 |
|
|
2021
Q1 | $4.66M | Buy |
128,664
+40,114
| +45% | +$1.42M | 0.16% | 167 |
|
|
2020
Q4 | $3.26M | Sell |
88,550
-11,124
| -11% | -$408K | 0.12% | 198 |
|
|
2020
Q3 | $3.47M | Sell |
99,674
-1,162
| -1% | -$40.7K | 0.15% | 172 |
|
|
2020
Q2 | $3.13M | Buy |
100,836
+4,439
| +5% | +$151K | 0.15% | 182 |
|
|
2020
Q1 | $2.99M | Sell |
96,397
-78,714
| -45% | -$2.68M | 0.17% | 164 |
|
|
2019
Q4 | $6.51M | Buy |
175,111
+73,424
| +72% | +$2.62M | 0.29% | 109 |
|
|
2019
Q3 | $3.47M | Buy |
101,687
+4,323
| +4% | +$157K | 0.17% | 160 |
|
|
2019
Q2 | $4M | Sell |
97,364
-87,600
| -47% | -$3.48M | 0.2% | 150 |
|
|
2019
Q1 | $7.45M | Buy |
184,964
+6,302
| +4% | +$252K | 0.39% | 68 |
|
|
2018
Q4 | $7.4M | Buy |
178,662
+21,164
| +13% | +$879K | 0.44% | 57 |
|
|
2018
Q3 | $6.59M | Buy |
157,498
+2,371
| +2% | +$91.3K | 0.41% | 66 |
|
|
2018
Q2 | $5.34M | Buy |
155,127
+49,774
| +47% | +$1.7M | 0.35% | 75 |
|
|
2018
Q1 | $3.55M | Buy |
105,353
+41,914
| +66% | +$1.44M | 0.24% | 132 |
|
|
2017
Q4 | $2.18M | Sell |
63,439
-5,892
| -8% | -$201K | 0.14% | 207 |
|
|
2017
Q3 | $2.36M | Buy |
69,331
+4,501
| +7% | +$145K | 0.15% | 182 |
|
|
2017
Q2 | $2.07M | Sell |
64,830
-5,966
| -8% | -$188K | 0.14% | 191 |
|
|
2017
Q1 | $2.3M | Buy |
70,796
+15,715
| +29% | +$495K | 0.16% | 171 |
|
|
2016
Q4 | $1.7M | Sell |
55,081
-113,612
| -67% | -$3.47M | 0.12% | 208 |
|
|
2016
Q3 | $5.42M | Buy |
+168,693
| New | +$5.64M | 0.38% | 62 |
|
|
2015
Q2 | – | Sell |
-165,478
| Closed | -$5.46M | – | 231 |
|
|
2015
Q1 | $5.46M | Sell |
165,478
-1,476
| -0.9% | -$46.9K | 0.38% | 66 |
|
|
2014
Q4 | $4.93M | Buy |
+166,954
| New | +$4.79M | 0.33% | 75 |
|
|
2013
Q4 | – | Sell |
-428,230
| Closed | -$11.7M | – | 241 |
|
|
2013
Q3 | $11.7M | Buy |
428,230
+20,675
| +5% | +$563K | 0.85% | 29 |
|
|
2013
Q2 | $10.8M | Buy |
+407,555
| New | +$11.3M | 0.85% | 32 |
|
Other funds holding PFE
Northwest & Ethical Investments's PFE Position: Q2 2026 in Review
Northwest & Ethical Investments reduced its Pfizer (PFE) stake by 40% in Q2 2026, selling an estimated $3.91M and leaving 221,058 shares worth $5.32M. The position accounts for 0.12% of the portfolio, ranked #131.
Northwest & Ethical Investments first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.8M in Q2 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Northwest & Ethical Investments held 221,058 shares of Pfizer worth $5.32M as of Q2 2026.
- Northwest & Ethical Investments sold 149,514 Pfizer shares in Q2 2026, an estimated $3.91M.
- Pfizer made up 0.12% of Northwest & Ethical Investments's portfolio in Q2 2026, its #131 holding.
- Northwest & Ethical Investments first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Northwest & Ethical Investments's Pfizer position peaked at $14.8M in Q2 2025.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.